SE7512341L - Nytt och forbettrat forfarande for framstellning avb 1,2,3,5-tetrahydroimidazo (2,1-6) kinazolin-2-oner - Google Patents

Nytt och forbettrat forfarande for framstellning avb 1,2,3,5-tetrahydroimidazo (2,1-6) kinazolin-2-oner

Info

Publication number
SE7512341L
SE7512341L SE7512341A SE7512341A SE7512341L SE 7512341 L SE7512341 L SE 7512341L SE 7512341 A SE7512341 A SE 7512341A SE 7512341 A SE7512341 A SE 7512341A SE 7512341 L SE7512341 L SE 7512341L
Authority
SE
Sweden
Prior art keywords
kinazolin
oners
tetrahydroimidazo
preparation
new
Prior art date
Application number
SE7512341A
Other languages
English (en)
Swedish (sv)
Inventor
W N Bevering
R A Partyka
T A Jenks
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of SE7512341L publication Critical patent/SE7512341L/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SE7512341A 1974-11-06 1975-11-04 Nytt och forbettrat forfarande for framstellning avb 1,2,3,5-tetrahydroimidazo (2,1-6) kinazolin-2-oner SE7512341L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/521,304 US3983119A (en) 1974-11-06 1974-11-06 Process for the preparation of optionally substituted 1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-ones

Publications (1)

Publication Number Publication Date
SE7512341L true SE7512341L (sv) 1976-05-07

Family

ID=24076219

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7512341A SE7512341L (sv) 1974-11-06 1975-11-04 Nytt och forbettrat forfarande for framstellning avb 1,2,3,5-tetrahydroimidazo (2,1-6) kinazolin-2-oner

Country Status (9)

Country Link
US (1) US3983119A (da)
JP (1) JPS5170797A (da)
CA (1) CA1055024A (da)
CH (1) CH618980A5 (da)
DK (1) DK490775A (da)
HU (1) HU175048B (da)
NL (1) NL7512965A (da)
SE (1) SE7512341L (da)
YU (2) YU40802B (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7807507A (nl) * 1977-07-25 1979-01-29 Hoffmann La Roche Tricyclische verbindingen.
US4208521A (en) * 1978-07-31 1980-06-17 Bristol-Myers Company Process for the preparation of imidazo[2,1-b]quinazolinones
JPS604186A (ja) * 1983-06-21 1985-01-10 Dai Ichi Seiyaku Co Ltd イミダゾキナゾリン化合物
JPS6028979A (ja) * 1983-07-14 1985-02-14 Dai Ichi Seiyaku Co Ltd イミダゾキナゾリン類化合物
US4645836A (en) * 1983-09-12 1987-02-24 Ortho Pharmaceutical Corporation Process for the preparation of 6,7-dihydroxy-4-alkyl-2(1H) quinazolinone-1-propionic acids
AU581205B2 (en) * 1984-02-15 1989-02-16 Syntex (U.S.A.) Inc. (2-oxo-1,2,3,5-tetrahydroimidazo-(2,1-B) quinazolinyl) oxyalkylamides
US4783467A (en) * 1985-06-05 1988-11-08 Pfizer Inc. Tetrahydroimidazoquinazolinone inotropic agents
US4837239A (en) * 1985-08-23 1989-06-06 Syntex (U.S.A.) Inc. Cardiotonic phosphodiesterase inhibitors complexed with water soluble vitamins
ES2344062T5 (es) * 2003-01-23 2013-04-26 Shire Biopharmaceuticals Holdings Ireland Limited Formulación y procedimientos para el tratamiento de la trombocitopenia
US20060030574A1 (en) * 2004-08-04 2006-02-09 Shire Holdings Ag Quinazoline derivatives useful for the treatment of peripheral arterial disease and as phosphodiesterase inhibitors
US7700608B2 (en) * 2004-08-04 2010-04-20 Shire Holdings Ag Quinazoline derivatives and their use in the treatment of thrombocythemia
US7910597B2 (en) * 2006-11-28 2011-03-22 Shire Llc Substituted quinazolines
US8304420B2 (en) 2006-11-28 2012-11-06 Shire Llc Substituted quinazolines for reducing platelet count
GB0808953D0 (en) * 2008-05-16 2008-06-25 Shire Llc substituted quinazolines
GB0808950D0 (en) * 2008-05-16 2008-06-25 Shire Llc Substituted quinazolines
GB0808944D0 (en) * 2008-05-16 2008-06-25 Shire Llc Substituted quinazolines
GB0808967D0 (en) * 2008-05-16 2008-06-25 Shire Llc Substitute quinazolines

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3257401A (en) * 1964-06-18 1966-06-21 Searle & Co 5-hydroxy-2-methylcycloalkyl[d] imidazo[1, 2-a]pyrimidines
US3600390A (en) * 1968-07-01 1971-08-17 Schering Corp Novel 5-phenyl imidazolidino(5,1-a)5h-quinazolines and process therefor
BE760013A (fr) * 1969-12-18 1971-06-08 Smith Kline French Lab Imidazo et pyrimido -(2,1-b)quinazolines, leurs procedes de preparationet compositions pharmaceutiques en contenant
US3745216A (en) * 1969-12-18 1973-07-10 Smith Kline French Lab Compositions and methods for producing hypotensive activity with imidazo and pyrimido(2,1-b)quinazoline compounds
US3790576A (en) * 1972-03-20 1974-02-05 Parke Davis & Co 9 substituted 4,9-dihydro-1,3,4,4-tetraalkyl-1h-pyrazolo(3,4-b)quinolines
US3859289A (en) * 1973-01-26 1975-01-07 Goetz E Hardtmann Tricyclic pyrimidinones

Also Published As

Publication number Publication date
JPS5170797A (en) 1976-06-18
DK490775A (da) 1976-05-07
CA1055024A (en) 1979-05-22
HU175048B (hu) 1980-05-28
US3983119A (en) 1976-09-28
NL7512965A (nl) 1976-05-10
CH618980A5 (da) 1980-08-29
YU113482A (en) 1982-10-31
YU279875A (en) 1982-10-31
YU40802B (en) 1986-06-30
JPS6259109B2 (da) 1987-12-09

Similar Documents

Publication Publication Date Title
SE413096B (sv) Forfarande for framstellning av 1alfa,24(s)-dihydroxikolekalciferol och/eller 1,24(r)-dihydroxikolekalciferol
SE7512341L (sv) Nytt och forbettrat forfarande for framstellning avb 1,2,3,5-tetrahydroimidazo (2,1-6) kinazolin-2-oner
SE434946B (sv) Forfarande for framstellning av acylsackariner och acyl-3-oxo-1,2-densisotiazoliner
SE7513085L (sv) Forfarande for framstellning av etrar
SE415126B (sv) Forfarande och tunnelugn for grafitering av kolkroppar
SE431746B (sv) Forfarande for framstellning av d-fenylglycinamid eller d-fenylglycin och l-fenylglycin
SE7506160L (sv) Forfarande for framstellning av n-cykloalkylmetyldekahydroisokinoline
SE421319B (sv) Forfarande for framstellning av etbara polysackarider och polysackaridderivat
SE425790B (sv) Forfarande for framstellning av polylaurinlactam
SU592355A3 (ru) Способ получени 2-карбалкоксиамино5(6)-фенилсульфонилоксибензимидазолов
SE7509909L (sv) Isolerat plastror och forfarande for tillverkning derav
SE7513753L (sv) Forfarande for framstellning av 8,8-disubstituerade-6-metylergoliner och derivat derav
SE430895B (sv) Forfarande for kontinuerlig framstellning av cellulosaglykolat
SE7511931L (sv) Penicilliner och forfarande for framstellning derav
SE411453B (sv) Forfarande for framstellning av 3-fluorcefalosporiner
SE403477B (sv) Forfarande for famstellning av substituerade indoleniner
SE7506107L (sv) Vulkbar komposition och forfarande.
SE426827B (sv) Nytt forfarande for framstellning av 7beta-acylamino-7alfa-alkoxicefalosporiner
SE7514113L (sv) 1-alkyl-2-(fenoximetyl)-5-nitroimidazoler och forfarande for deras framstellning
SU569283A3 (ru) Способ получени симметричных окситиоалканов
SE407150B (sv) Injektionsspruta och forfarande for framstellning av densamma
SE7511801L (sv) Forfarande for framstellning av ympsampolymerisat
SE7512422L (sv) Forfarande for framstellning av 1,2,3,4-tetrahydroisokinoliner
SE7808849L (sv) Forfarande for framstellning av 9,11,15-trihydroxi-13,14-dehydroprostaglandiner och prost-5-en-13-ynsyraderivat
SE417086B (sv) Forfarande for framstellning av 2-etylindan och 2-isopropylindan